The aim of the European Partnership for Personalised Medicine is to improve health outcomes within sustainable healthcare systems through research, development, innovation and the implementation of personalised medicine approaches for the benefit of patients, citizens and society.
The overall objective of the JTC2027 is to fund research projects in human health focusing on cell and gene therapies (CGT) for personalised medicine (PM) approaches. Proposals must focus on the development and validation of innovative and novel CGT approaches for PM. At least one of the following approaches must be employed:
Somatic cell therapeutics (e.g. stem cells, organoids or cells of the immune system);
Gene therapeutics in the form of gene substitution, addition or suppression therapies using viral and non-viral vectors or genome editing;
Combined cell and gene therapeutics in the form of genetically modified cells;
Novel biological products, such as mRNA, other nucleic acid-based methods and extracellular vesicles, as vehicles for gene-based therapeutic procedures.
A two-step submission and evaluation procedure has been established for joint applications. In addition to submitting an international project proposal to the Call Secretariat, researchers from Türkiye participating in the projects are also required to submit a national project application to TÜBİTAK via the Project Application System.
Project proposals submitted from Türkiye under this call will be supported through the TÜBİTAK 1071 Support Program for Increasing the Capacity to Benefit from International Research Funds and Participation in International R&D Collaborations.
Detailed information about the call and the national application rules can be found in the call document below.
Call Timeline:
Deadline for Submission of Stage 1 Proposals to the Joint Call Secretariat: 20 January 2027 (14:00, CET)
Deadline for the TÜBİTAK National Application of the Stage 1 Proposals: 27 January 2027 (23:59, UTC+3)
Deadline for Submission of Stage 2 Proposals to the Joint Call Secretariat: 25 May 2027 (14:00, CEST)
Contact:
EP PerMed and International Application Rules:
Assoc. Prof. Dr. N. Selcan TÜRKER
+90 312 2981760
TÜBİTAK 1071 Program and National Application Rules:
Azmi Serhat YILDIRIM
azmiserhat.yildirim@tubitak.gov.tr
+90 312 2981823
